Active, Not Recruiting
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
NCT05907304
- Conditions
- Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States